Hainan Haiyao: Announcement of Resolutions of the 21st Meeting of the 11th Board of Directors
Hainan Haiyao: A rectification report on the Hainan Securities Regulatory Bureau\'s decision to order the company to take corrective measures
Hainan Haiyao: Announcement on Change of Sponsor Representative
Hainan Haiyao: Announcement on cooperation between the company and New Zealand AFT Pharmaceuticals Ltd on exclusive commercialization rights for related products
Hainan Haiyao: Announcement on Signing an Enforcement Settlement Agreement
Hainan Haiyao: Announcement on Adding Provisional Proposals for the 2024 Third Extraordinary General Meeting of Shareholders and Supplementary Notice of Convening the 2024 Third Extraordinary General Meeting of Shareholders
Hainan Haiyao: Announcement on the consistent evaluation of the quality and efficacy of generic drugs with aztreonam for injection
Hainan Haiyao: Announcement of Resolutions of the 20th Meeting of the 11th Board of Directors
Hainan Haiyao: Announcement of Resolutions of the 19th Meeting of the 11th Board of Directors
Hainan Haiyao: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Hainan Haiyao: Announcement on Renewal of the Accounting Firm
Hainan Haiyao: Progress Notice on the Formal Signing of the Initial Joint Venture Contract
Hainan Haiyao: Announcement of Resolutions of the 18th Meeting of the 11th Board of Directors
Hainan Haiyao: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Hainan Haiyao: Legal Opinion on the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Haiyao Co., Ltd.
Hainan Haiyao: Notice on receiving the Hainan Securities Regulatory Bureau\'s decision on administrative supervision measures
Hainan Haiyao: Announcement of Resolutions of the 17th Meeting of the 11th Board of Directors
Hainan Haiyao: Announcement on Signing the Initial Joint Venture Contract
Hainan Haiyao: Announcement on Abnormal Fluctuations in Stock Trading
Hainan Haiyao: Report for the third quarter of 2024
No Data